These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20556769)

  • 1. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
    Dodd JM; McLeod A; Windrim RC; Kingdom J
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006780. PubMed ID: 20556769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction.
    Dodd JM; McLeod A; Windrim RC; Kingdom J
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006780. PubMed ID: 23884904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
    Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD;
    Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin therapy for complications of placental dysfunction: a systematic review of the literature.
    Dodd JM; Sahi K; McLeod A; Windrim RC; Kingdom JP
    Acta Obstet Gynecol Scand; 2008; 87(8):804-11. PubMed ID: 18704775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes.
    Buppasiri P; Lumbiganon P; Thinkhamrop J; Ngamjarus C; Laopaiboon M
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007079. PubMed ID: 21975761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E supplementation in pregnancy.
    Rumbold A; Crowther CA
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004069. PubMed ID: 15846695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction.
    Makrides M; Duley L; Olsen SF
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003402. PubMed ID: 16856006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise for pregnant women for preventing gestational diabetes mellitus.
    Han S; Middleton P; Crowther CA
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009021. PubMed ID: 22786521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Techniques of intrauterine fetal transfusion for women with red-cell isoimmunisation for improving health outcomes.
    Dodd JM; Windrim RC; van Kamp IL
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007096. PubMed ID: 20556774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidants for preventing pre-eclampsia.
    Rumbold A; Duley L; Crowther C; Haslam R
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004227. PubMed ID: 16235354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet agents for preventing and treating pre-eclampsia.
    Knight M; Duley L; Henderson-Smart DJ; King JF
    Cochrane Database Syst Rev; 2000; (2):CD000492. PubMed ID: 10796208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group versus conventional antenatal care for women.
    Homer CS; Ryan C; Leap N; Foureur M; Teate A; Catling-Paull CJ
    Cochrane Database Syst Rev; 2012 Nov; 11():CD007622. PubMed ID: 23152247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet and exercise interventions for preventing gestational diabetes mellitus.
    Bain E; Crane M; Tieu J; Han S; Crowther CA; Middleton P
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010443. PubMed ID: 25864059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques of intrauterine fetal transfusion for women with red-cell isoimmunisation for improving health outcomes.
    Dodd JM; Windrim RC; van Kamp IL
    Cochrane Database Syst Rev; 2012 Sep; (9):CD007096. PubMed ID: 22972102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis.
    Cruz-Lemini M; Vázquez JC; Ullmo J; Llurba E
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1126-S1144.e17. PubMed ID: 34301348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium sulphate for women at term for neuroprotection of the fetus.
    Nguyen TM; Crowther CA; Wilkinson D; Bain E
    Cochrane Database Syst Rev; 2013 Feb; (2):CD009395. PubMed ID: 23450601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies.
    Griffin M; Heazell AEP; Chappell LC; Zhao J; Lawlor DA
    Syst Rev; 2020 Apr; 9(1):78. PubMed ID: 32268905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Antiplatelet agents for preventing and treating pre-eclampsia.
    Knight M; Duley L; Henderson-Smart DJ; King JF
    Cochrane Database Syst Rev; 2007 Jul; 2007(2):CD000492. PubMed ID: 17636639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications.
    Rodger MA; Carrier M; Le Gal G; Martinelli I; Perna A; Rey E; de Vries JI; Gris JC;
    Blood; 2014 Feb; 123(6):822-8. PubMed ID: 24357725
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.